Skip to main content

Table 5 2018–2019 Comparison of Utilization Frequency of Screening Tools in Clinic

From: Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)

  Each frequency comparison
2018 Responsea 2019 Response p value
Tools are administered as concerns appear during developmental surveillance    < 0.0001
 Yes 32.7% 8.0%  
 No 67.3% 92.0%  
Tools are administered at 9-, 18-, and 30-month visits    < 0.0001
 Yes 41.3% 15.0%  
 No 58.7% 85.0%  
Tools are administered at each well visit    < 0.0001
 Yes 56.0% 37.3%  
 No 44.0% 62.7%  
Tools are administered at 9-, 18-, and 30-month visits and as concerns appear during developmental surveillance    < 0.0001
 Yes 18.0% 35.7%  
 No 82.0% 64.3%  
Tools are not administered in practice    Option not provided in 2018 Survey
 Yes   4.0%
 No   96.0%
  1. In 2019, respondents were instructed to select the option that best described the frequency of tool administration within their practice. aIn 2018 each pediatrician had the option to ‘select all that apply’ for the following provided responses: Tools are administered as concerns appear during developmental surveillance; Tools are administered at 9-, 18-, and 30-month visits; Tools are administered at each well visit. Respondents that selected both ‘Tools are administered as concerns appear during developmental surveillance’ and ‘Tools are administered at 9-, 18-, and 30-month visits’ were also listed within the row labeled ‘Tools are administered at 9-, 18-, and 30-month visits and as concerns appear during developmental surveillance’